Medscape Report Finds Cytoreductive Surgery During TKI Therapy May Extend Survival in EGFR-Mutated Lung Cancer Patients

A Medscape report published June 22, 2026 citing a June 11 International Journal of Cancer study found cytoreductive surgery during TKI therapy may extend survival in EGFR-mutated NSCLC.